Clinical Trial Update: Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating Saccharomyces boulardii in patients with liver cirrhosis on the liver transplant waiting list.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Liver Cirrhosis | Phase 2 | Status: COMPLETED